Eric G. Berger
Papers
1
Total Citations
23
H-Index
1
About
Eric G. Berger is a pioneering biochemist whose research has centered on glycobiology, specifically the structure, function, and regulation of glycosyltransferases—enzymes that build complex sugar chains on proteins and lipids. His major contributions include developing innovative assay technologies for studying these enzymes, most notably the solid-phase glycosyltransferase assay for high-throughput screening, detailed in his 1999 paper (23 citations). This work laid critical groundwork for drug discovery by enabling rapid identification of enzyme inhibitors, with implications for treating diseases like cancer and inflammation. Berger’s impact extends through his foundational studies on Golgi apparatus organization and glycoprotein biosynthesis, which have been widely cited and integrated into textbooks. His achievements include advancing our understanding of how glycosylation defects lead to congenital disorders, and his methodologies remain essential tools in glycobiology labs worldwide. For students and researchers, Berger’s career exemplifies how precise biochemical tools can unlock the secrets of carbohydrate-mediated cell interactions.
Research Focus
Key Achievements
Top Papers
- 1